Last reviewed · How we verify
NCT02968836
Safety and Efficacy of an Amino Acid Blend on Muscle and Gut Functionality in ICU Patients
NA trial testing Blend of amino acids in Enteral Nutrition in 35 participants. Completed in 31 December 2019.
30 September 2019
Quick facts
| Lead sponsor | Société des Produits Nestlé (SPN) |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | supportive care |
| Enrollment | 35 |
| Start date | 1 June 2017 |
| Primary completion | 30 September 2019 |
| Estimated completion | 31 December 2019 |
| Sites | 1 location across France |
Drugs / interventions tested
- Blend of amino acids
- Maltodextrin only
Conditions studied
- Enteral Nutrition — all drugs for Enteral Nutrition →
Sponsor
Société des Produits Nestlé (SPN) — full company profile →
Who can join
18 and older, any sex, with Enteral Nutrition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Assessment of the Safety and efficacy of an amino acid blend on muscle and gut functionality in Intensive Care Unit (ICU) patients. Since this was a proof of concept, exploratory trial, we assessed different primary outcomes without hierarchy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of an enteral amino acid blend on muscle and gut functionality in critically ill patients: a proof-of-concept randomized controlled trial.
Heming N, Carlier R, Prigent H, Mekki A, et al · · 2022 · cited 8× · PMID 36397118 · DOI 10.1186/s13054-022-04232-5
Verify or expand the search:
- PubMed search for NCT02968836
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Enteral Nutrition
Currently open trials in the same condition.
- NCT07307027 — Stepwise Enteral Nutritional Algorithm and Patient Outcomes in Pediatric Intensive Care Units · NA · recruiting
Other Société des Produits Nestlé (SPN) trials
Trials by the same sponsor.
- NCT07312201 — Oral Nutritional Supplementation in Children With Growth Concerns · NA · not yet recruiting
- NCT07378111 — Vegetarian Tube Feed Study · NA · not yet recruiting
- NCT07439718 — The Effects of an Oral Nutritional Intervention on the Small Intestine Microbiome · NA · recruiting
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07127198 — Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02968836 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Société des Produits Nestlé (SPN)
- Last refreshed: 2 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02968836.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing